These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. The effect of fellow eye visual acuity on visual acuity of study eyes receiving ranibizumab for age-related macular degeneration. Zweifel SA; Saroj N; Shapiro H; Freund KB Retina; 2012 Jul; 32(7):1243-9. PubMed ID: 22466461 [TBL] [Abstract][Full Text] [Related]
13. TREATMENT OUTCOMES FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION PATIENTS WITH INITIAL VISION BETTER THAN 20/40 USING A TREAT-AND-EXTEND REGIMEN. Rahimy E; Rayess N; Ho AC; Regillo CD Retina; 2016 May; 36(5):875-80. PubMed ID: 26630316 [TBL] [Abstract][Full Text] [Related]
14. Twenty-four-month efficacy and safety of 0.5 mg or 2.0 mg ranibizumab in patients with subfoveal neovascular age-related macular degeneration. Ho AC; Busbee BG; Regillo CD; Wieland MR; Van Everen SA; Li Z; Rubio RG; Lai P; Ophthalmology; 2014 Nov; 121(11):2181-92. PubMed ID: 25015215 [TBL] [Abstract][Full Text] [Related]
15. Association between choroidal thickness and the response to intravitreal ranibizumab injection in age-related macular degeneration. Shin JY; Kwon KY; Byeon SH Acta Ophthalmol; 2015 Sep; 93(6):524-32. PubMed ID: 25581639 [TBL] [Abstract][Full Text] [Related]
16. Effects of Vitreomacular Traction on Ranibizumab Treatment Response in Eyes with Neovascular Age-related Macular Degeneration. Lee KH; Chin HS; Kim NR; Moon YS Korean J Ophthalmol; 2015 Dec; 29(6):396-403. PubMed ID: 26635456 [TBL] [Abstract][Full Text] [Related]
17. Switch to Aflibercept in the Treatment of Neovascular AMD: One-Year Results in Clinical Practice. Pinheiro-Costa J; Costa JM; Beato JN; Freitas-da-Costa P; Brandão E; Falcão MS; Falcão-Reis F; Carneiro ÂM Ophthalmologica; 2015; 233(3-4):155-61. PubMed ID: 25896317 [TBL] [Abstract][Full Text] [Related]
18. Evaluating the impact of summer vacation on the visual acuity of AMD patients treated with ranibizumab. Massamba N; Dirani A; Knoeri J; Pasquier B; Ingram A; Soubrane G Eye (Lond); 2015 Nov; 29(11):1453-7. PubMed ID: 26206530 [TBL] [Abstract][Full Text] [Related]
19. Predictors of 1-year visual outcome in neovascular age-related macular degeneration following intravitreal ranibizumab treatment. Bloch SB; la Cour M; Sander B; Hansen LK; Fuchs J; Lund-Andersen H; Larsen M Acta Ophthalmol; 2013 Feb; 91(1):42-7. PubMed ID: 22008284 [TBL] [Abstract][Full Text] [Related]
20. Comparison of outcomes after switching treatment from intravitreal bevacizumab to ranibizumab in neovascular age-related macular degeneration. Kent JS; Iordanous Y; Mao A; Powell AM; Kent SS; Sheidow TG Can J Ophthalmol; 2012 Apr; 47(2):159-64. PubMed ID: 22560422 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]